Analysis of analgesic effect of vitamin C combined with sufentanil after laparoscopic total hysterectomy

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100048799

Enrollment

Unknown

Registered

2021-07-16

Start date

2021-07-19

Completion date

Unknown

Last updated

2022-03-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Laparoscopic total hysterectomy

Interventions

Group S:Routine use of postoperative analgesia pump

Group SC1:Routine use of postoperative analgesia pump +vitimia C3g

Group SC2:Routine use of postoperative analgesia pump +???C6g

Eligibility

Sex/Gender

Female

Age

40 Years to 60 Years

Inclusion criteria

Inclusion criteria: The patients, aged 40-60 years old, BMI18.5-23.9 grade Asa I or II, who underwent elective laparoscopic total hysterectomy under general anesthesia in our hospital were included.

Exclusion criteria

Exclusion criteria: Complicated with severe respiratory and circulatory diseases, nervous system diseases, mental and psychological diseases, history of chronic pain, obvious abnormalities of liver and kidney function, pregnant and lactating women.

Design outcomes

Primary

Measure	Time frame
VAS;	—

Secondary

Measure	Time frame
5-HT;NE;	—

Countries

China

Contacts

Public ContactLi Yan

Chengde Medical College

liyan0567@126.com+86 15633142990

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026